A GEP analysis of T-cell non-Hodgkin's lymphoma samples, including angioimmunoblastic lymphomas (AILT), ALK positive ALCL, ALK negative ALCL, PTCL-NOS and normal T-cells, identified a genomic classifier for the recognition of ALCL patients [16]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.